Alere, Inc. and its San Diego subsidiary, agreed to pay $38.75 million to resolve False Claims Act charges for billing the Medicare program for defective rapid point-of-care testing devices.

Alere investors went on a wild ride in the last 24 hours as the shares plunged following a report of a second Justice Department investigation of the medical test maker, then rebounded after the ...

Abbott Laboratories, a health care product maker, filed Wednesday a complaint to end its deal to acquire diagnostics-testing company Alere, citing “damaging business developments” at Alere.

There were good feelings all around when Abbott Laboratories said in February it would pay $5.8 billion for Alere Inc., a Waltham company that had emerged as a global leader in “point-of-care ...

Alere Inc., which is grappling with foreign corruption probes, said it recently rejected an offer of up to $50 million by Abbott Laboratories to terminate their $5.8 billion merger agreement. An ...

Over the past 12 months, Alere generated $182.3 million cash while it booked a net loss of $78.2 million. That means it turned 6.5% of its revenue into FCF. That sounds OK. All cash is not equal ...